Long-term hormonal therapy resulting in breast cancer in female-to-male transsexual: Case report
Language English Country United States Media print
Document type Case Reports, Journal Article
PubMed
30593135
PubMed Central
PMC6314692
DOI
10.1097/md.0000000000013653
PII: 00005792-201812280-00011
Knihovny.cz E-resources
- MeSH
- Long Term Adverse Effects chemically induced MeSH
- Hormone Replacement Therapy adverse effects MeSH
- Middle Aged MeSH
- Humans MeSH
- Breast Neoplasms chemically induced MeSH
- Testosterone adverse effects MeSH
- Transsexualism drug therapy MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Case Reports MeSH
- Names of Substances
- Testosterone MeSH
RATIONALE: Testosterone is important for the development of secondary sexual characteristics in female-to-male transsexuals. On the contrary, it can increase the risk of breast cancer. PATIENT CONCERNS: We present a rare case of breast cancer in female-to-male transsexual patient after long-term hormonal therapy. DIAGNOSIS: Breast cancer in female-to-male transsexual patient. INTERVENTIONS: The patient underwent mastectomy and chemotherapy. OUTCOMES: The patient had local recurrence of the disease and he underwent re-excision, radiotherapy and the tamoxifen treatment. After this treatment, the patient is in the remission from the disease. LESSONS: Breast cancer in transsexuals appears to be rare. However, there is a potential risk that testosterone exposure can increase the risk of developing breast cancer by the stimulation of breast tissue. There is limited published literature on the risk of breast cancer in transsexual patients.
See more in PubMed
Shao T, Grossbard ML, Klein P. Breast cancer in female-to-male transsexuals: two cases with a review of physiology and management. Clin Breast Cancer 2011;11:417–9. PubMed
Gooren LJ, van Trotsenburg MA, Giltay EJ, et al. Breast cancer development in transsexual subjects receiving cross-sex hormone treatment. J Sex Med 2013;10:3129–34. PubMed
Katayama Y, Motoki T, Watanabe S, et al. A very rare case of breast cancer in a female-to-male transsexual. Breast Cancer 2016;23:939–44. PubMed
Slagter MH, Scorilas A, Gooren LJ, et al. Effect of testosterone administration on serum and urine kallikrein concentrations in female-to-male transsexuals. Clin Chem 2006;52:1546–51. PubMed
Burgess HE, Shousha S. An immunohistochemical study of the long-term effects of androgen administration on female-to-male transsexual breast: a comparison with normal female breast and male breast showing gynaecomastia. J Pathol 1993;170:37–43. PubMed
Gooren L, Bowers M, Lips P, et al. Five new cases of breast cancer in transsexual persons. Andrologia 2015;47:1202–5. PubMed
Brown GR, Jones KT. Incidence of breast cancer in a cohort of 5,135 transgender veterans. Breast Cancer Res Treat 2015;149:191–8. PubMed
Pattison ST, McLaren BR. Triple negative breast cancer in a male-to-female transsexual. Intern Med J 2013;43:203–5. PubMed
Corman V, Potorac I, Manto F, et al. Breast cancer in a male-to-female transsexual patient with a BRCA2 mutation. Endocr Relat Cancer 2016;23:391–7. PubMed